Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
-
Published:2023-04
Issue:
Volume:178
Page:20-27
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Zhuang Fenghui, Haoran E, Huang Jia, Wu Junqi, Xu Long, Zhang Lei, Li Qiang, Li Chongwu, Zhao Yue, Yang Minglei, Ma Minjie, She Yunlang, Chen Hezhong, Luo Qingquan, Zhao Deping, Chen ChangORCID
Funder
Shanghai Hospital Development Center National Key Research and Development Program of China Shanghai Municipal Health Commission Science and Technology Commission of Shanghai Municipality National Natural Science Foundation of China
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference51 articles.
1. The promise of neoadjuvant immunotherapy and surgery for cancer treatment;O'Donnell;Clin. Cancer Res.,2019 2. R.N. Amaria, A.M. Menzies, E.M. Burton, R.A. Scolyer, M.T. Tetzlaff, R. Antdbacka, C. Ariyan, R. Bassett, B. Carter, A. Daud, M. Faries, L.A. Fecher, K.T. Flaherty, J.E. Gershenwald, O. Hamid, A. Hong, J.M. Kirkwood, S. Lo, K. Margolin, J. Messina, M.A. Postow, H. Rizos, M.I. Ross, E.A. Rozeman, R.P.M. Saw, V. Sondak, R.J. Sullivan, J.M. Taube, J.F. Thompson, B.A. van de Wiel, A.M. Eggermont, M.A. Davies, P.A. Ascierto, A.J. Spillane, A.C.J. van Akkooi, J.A. Wargo, C.U. Blank, H.A. Tawbi, G.V. Long, Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium, Lancet Oncol. 20(7) (2019) e378-e389. 3. G. Curigliano, H.J. Burstein, E.P. Winer, M. Gnant, P. Dubsky, S. Loibl, M. Colleoni, M.M. Regan, M. Piccart-Gebhart, H.J. Senn, B. Thürlimann, F. André, J. Baselga, J. Bergh, H. Bonnefoi, S.Y. Brucker, F. Cardoso, L. Carey, E. Ciruelos, J. Cuzick, C. Denkert, A. Di Leo, B. Ejlertsen, P. Francis, V. Galimberti, J. Garber, B. Gulluoglu, P. Goodwin, N. Harbeck, D.F. Hayes, C.S. Huang, J. Huober, K. Hussein, J. Jassem, Z. Jiang, P. Karlsson, M. Morrow, R. Orecchia, K.C. Osborne, O. Pagani, A.H. Partridge, K. Pritchard, J. Ro, E.J.T. Rutgers, F. Sedlmayer, V. Semiglazov, Z. Shao, I. Smith, M. Toi, A. Tutt, G. Viale, T. Watanabe, T.J. Whelan, B. Xu, De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017, Ann. Oncol. 28(8) (2017) 1700-1712. 4. Neoadjuvant PD-1 blockade in resectable lung cancer;Forde;N. Engl. J. Med.,2018 5. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial;Shu;Lancet Oncol.,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|